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Abstract
Whipple's pancreaticoduodenectomy has been refined
over the years to be a safe operation though the
morbidity rate still remains high (30-50%). Pancreatic
fistula is the most important cause of mortality
following pancreaticoduodenectomy. To prevent it,
surgeons have used two anastomotic techniques:
pancreaticojejunostomy and pancreaticogastrostomy.
Recent studies found that pancreaticogastrostomy is
associated with fewer overall complications than
pancreaticojejunostomy. 
This is a retrospective review of patients who underwent
Whipple's at Aga Khan University Hospital and had
pancreaticogastrostomy as a preferred anastomosis for
pancreatic stump.
Forty four patients met the inclusion criteria, 27 were
male. No patient developed post-operative pancreatic
fistula, 13 (31%) patients had morbidities including
delayed gastric emptying 4(9.1%), wound infection
3(6.8%), and haemorrhage 6(13.6%). Mortality is reported
to be 5 (11.9%).
Pancreaticogastrostomy seems to be a safe alternative
and easier anastomosis to perform with less post-
operative morbidity and mortality. Further data should
become available with greater numbers in the future.
Keywords:Pancreaticogastrostomy, Pancreatic anastomosis,
Pancreatic leak.
Introduction
Pancreaticoduodenectomy (PD) has become increasingly
acceptable as a safe and appropriate surgical technique
for managing malignant or benign diseases of the head of
the pancreas and periampullary region.1
First successful PD was done by Walter Kausch in 1912.
Allen Whiple in 1935,2 introduced and popularized the
operation. Cameron in 1993 presented his case series of
145 consecutive PD from Johns Hopkins Medical institute.
Initially Pancreaticoenteric anastomoses was not included
as part of PD. Therefore it was associated with high
morbidity and mortality resulting from high rates of
leakage from pancreatic stump.
Pancreatcogastrostomy is a repopularized technique
which has been described previously in literature.3 This
study was done to review the experience of PG being
done as an alternate to PJ after PD.
Material and Methods
It is a case series collected at the Department of Surgery of
Aga Khan University Hospital, Karachi from July 2008 till
March 2016. This case series includes all adult patients
who were diagnosed to have peri-ampullary mass on
preoperative imaging and underwent Pancreatico-
duodenectomy (Whipple procedure) with pancreatico-
gastrostomy as preferred anastomoses, instead of
pancreatico-jejunostomy, to maintain pancreatico-
enteric continuity. Retrospective review of files of these
patient's was done and  a detailed performa was
developed to record information on patient's
demographics, clinical features, haematological and
radiological investigations, preoperative ERCP and
stenting, final histopathology, surgical details and
duration of hospital stay. Postoperative 30-day mortality
and morbidity (including postoperative pancreatic fistula,
delayed gastric emptying, haemorrhage and wound
infection) were also recorded. The data were analyzed by
using Statistical Package for the Social Sciences (SPSS
version 20.0). Quantitative variables are reported as
means ± standard deviations, Qualitative variables are
reported as proportions and percentages. This case series
was approved by hospital Ethical Review Committee (ERC
number 4083-Sur-ERC-16).
Results
A total of 44 patients were included in this case series, of
whom 17 patients were females and 27 were males. Mean
age was 55.5±11.5 years. Most commonly occurring
comorbidity was Hypertension (18 patients) and Diabetes
Mellitis (14 patients). Most common presenting complaint
was jaundice (35 patients, 79.5 %) followed by abdominal
pain (25 patients 56.8%). CT Scan Abdomen was used as
main diagnostic and staging tool and was done in all
patients. A total of13(29.6%) patients underwent ERCP, 9
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(20.5%) had stent placement and10 (22.30%) patients had
endoscopic biopsy as well.  Peroperatively pancreas was
found to be firm in seven patients, soft in eleven patients
and in rest consistency was not documented. Mean
duration of surgery was 7.14±1.0 hours. Mean time period
to establish oral feeding was 7±1.9 days. Final
histopathology of the resected specimen was
ampullaryadeno carcinoma in 16 (36.4%) patients,
carcinoma head of pancreas in 11(25.0%) patients, adeno
carcinoma Distal CBD in 8 (18.2%) patients and adeno
carcinoma duodenum in 4(9.1%) patients, (Table-1). All
resected specimens had tumour free margins, except
1which was borderline resectable to start with. In 17
patients lymph nodes were positive for metastases. Mean
duration of hospital stay was 14.1±5.6 days. All the cases
were discussed in multidisciplinary meeting (tumor
board) after surgery and were referred for adjuvant
chemo-radiotherapy where necessary.
Post-operative morbidities were reported in 14 patients.
Four patients had delayed gastric emptying, all were
managed conservatively, and 3 had wound infection. A
total of 6 patients had Intraluminal gastro-intestinal
haemorrhage; 2 patients had bleeding from
pancreaticogastrostomy and 1 had bleeding from
gastrojejunostomy site, out of these 3 patients, one was
re-explored after endovascular attempts but died even
after all measures and 2 patient were attempted to be
managed via endovascular means but only one endeavor
was successful. The other 3 patients were managed
conservatively and required no intervention for control of
haemorrhage. One patient had a leak from
choledochojejunostomy site which was managed
conservatively by PTC drainage. None of our patients
developed pancreatic fistula. Five patients expired, 2 due
to non-surgical causes, one had massive pulmonary
embolism and the other suffered from aspiration
pneumonia, acute kidney injury and atrial fibrillation. One
patient had ongoing sepsis because of persistent
postoperative cholangitis. The other 2 patients died of
massive gastrointestinal hemorrhage.
Discussion
Pancreaticoenteric anastomoses for the first time was
introduced by Whipple4 in 1945. Throughout 1960s
and 70s this procedure was associated with high
morbidity and mortality.5 However current statistics
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Table-1: Demographic and clinico-pathological data.
Variables                                                                                                               Frequencies
Total no. patients  (N)                                                                                                     44
Age
Mean                                                                                                                 55.5 years (SD ±11.5)
Gender
Male                                                                                                                            27 (61.4 %)
Female                                                                                                                        17  (38.6%)
Presenting complaint
Nausea                                                                                                                         12 (27.3%)
Weight loss                                                                                                                16 (36.4%)
Abdominal pain                                                                                                        25 (56.8%)
Jaundice                                                                                                                      35 (79.5%)
Preoperative stenting                                                                                              9 (20.5%)
Histopathology
AmpullaryAdenocarcinoma                                                                                  16 (36.4%)
Adenocarcinoma CBD                                                                                              8 (18.2%)
Adenocarcinoma Duodenum                                                                                  4 (9.1%)
Carcinoma head of Pancreas                                                                               11  (25.0%)
Distal CBD Cholangiocarcinoma                                                                            2 (4.5%)
Chronic Pancreatitis                                                                                                   2 (4.5%)
GIST duodenum                                                                                                          1 (2.3%)
Duration of Surgery (mean)                                                                        7.14 hours (SD±1.0)
Duration of hospital stay (mean)                                                                14.1 days (SD±5.6)
Morbidity
Pancreatic leak/Fistula                                                                                                NONE
Delayed Gastric emptying                                                                                       4 (9.1%)
Haemorrhage                                                                                                             6 (13.6%)
Wound infection                                                                                                         3 (6.8%)
Choledocho-jejunostomy leak                                                                               1 (2.3%)
Mortality                                                                                                                      5 (11.4%)
SD: Standard deciation. CBD: Common bile duct. GIST: Gastrointestinal stromal tumour.
Figure-1: Pancreaticogastrostomy.
show that preoperative mortality after PD has
decreased to < 5% in high volume centers, probably
because of innovation in surgical techniques and
development in perioperative care.6,7 But post-
operative morbidity of pancreatic resection continues
to remain 30 - 50%.8 Most common postoperative
complications include: Delayed gastric emptying (19-
23%), Anastomotic leakage or fistula from
pancreaticoenetrostomy (9-18%), Intra-abdominal
abscess (9-10%) and Gastrointestinal or intra-
abdominal hemorrhage (1- 8%).
Among the above mentioned complications the most
dreadful and important of all is proven to be formation of
pancreatic fistula.8-10 Incidence of pancreatic fistula after
PD ranges from 6% to 24% (mean 13.6%), resulting in
mortality rates of approximately 8-40%, (mean 12.5%).
Pancreatic fistula is diagnosed as amylase activity in
peritoneal fluid greater than three times the upper serum
normal value after 3rd post-operative day.10 The
independent risk factors associated with high incidence
of pancreatic leak are: Type of pancreaticoenteric
anastomosis, Soft pancreas, Duration of surgery (> 6 - 8
hours), Intraoperative blood loss, Ischaemia and Surgeon
volume.
To minimize leak rates, over 70 technique variations of PJ
have been suggested in literature, whether the
modifications of PJ really reduce leak rates or not is still a
matter of great debate.8
Recently repopularized option for enteric drainage of the
pancreatic remnant is Pancreaticogastrostomy. This
technique was first reported in literature in 1934 by
Tripodi.3 In 1946 it was described in detail by Waugh and
Clagett.11
Pancreaticogastric anastomoses in our cases was
undertaken as; Pancreatic stump was anastomosed
with posterior wall of stomach. After preparing the
pancreatic stump, anterior capsule of pancreas was
sutured with posterior wall of stomach, using 3.0 PDS
interrupted sutures. Gastrostomy is made after this
step, parallel to the suture line. Next step was to suture
posterior capsule of the pancreatic stump to the other
lip of gastrostomy with the help of 3.0 PDS interrupted
sutures as shown in Figure-1.12 After completion of this
anastomosis, pancreatic stump protruded into the
lumen of stomach up to 1 cm. As a routine we measured
drain amylase level if there was considerable output
from the drain.
Advantages of pancreatico gastrostomy over
pancreaticojejunostomy are as follows:
- Anastomosis  is protected against enzymatic damage
because of acidic environment of stomach which
inactivates the pancreatic proteolytic enzymes.13
- It is known to be a technically easier and tension-free
anastomosis as the posterior wall of the stomach lies
immediately anterior to the mobilized pancreatic
remnant, which acts not only as a thick suture bed for the
anastomosis, but has an excellent blood supply as well
when compared to the jejunum. Moreover absence of a
long jejunal loop eliminates the hanging effect of it.13,14
- Early detection of bleeding from the pancreatic remnant
or the anastomosis can be done by routine N/G
decompression and direct examination of the
anastomosis can be performed by endoscopy.15
- If needed (in case of intraluminal bleeding), easy
exploration of the anastomosis can be undertaken by
opening the anterior wall of the stomach, without
disassembling the pancreatic anastomosis.15
The results of earlier prospective randomized trial
conducted by Yeo et al16 comparing PG with PJ suggested
that surgical volume and soft pancreatic texture were the
most significant factors associated with pancreatic fistula.
In our study eleven of our patients had soft pancreas but
none of them developed pancreatic fistula.
Most randomized control trials and meta analyses done in
recent years suggest that PG is associated with reduced
incidence of overall postoperative complications,
pancreatic fistula and intra-abdominal collections,17-24
when compared with PJ after PD; making it a safer
anastomoses to perform with respect to immediate
postoperative morbidity.
We are a low volume center (approximately 5
pancreaticoduodenectomy/ year) and our mortality rate
was 11.4%. This is higher than those reported by large
volume centers but comparable to reports from other
regional centers.25-28 As our surgical experience and
volume increases, along with better critical care
management, the mortality rates are likely to decrease in
future.
Conclusion
Pancreatic anastomosis is precious anastomoses because
of its associated high morbidity. In our experience we
found PG not only technically simple but a safe procedure
in both firm and soft pancreas, with regards to
postoperative pancreatic fistula.
Disclaimer: None to declare.
Conflict of Interest: None to declare.
Vol. 67, No. 10, October 2017
Pancreaticogastrostomy — an alternate for dealing with pancreatic remnant after pancreaticoduodenectomy... 1623
Funding Disclosure: None to declare
References
1. Kapur BM, Misra MC, Seenu V, Goel AK. Pancreaticogastrostomy
for reconstruction of pancreatic stump after
pancreaticoduodenectomy for ampullary carcinoma. Am J Surg
1998; 176: 274-8. 
2. Whipple AO, Parsons WB, Mullins CR. Treatment of Carcinoma of
the Ampulla of Vater. Ann Surg 1935; 102: 763-79. 
3. Tripodi A. Experimental transplantation of the pancreas into the
stomach. Arch Surg 1934; 28: 345-56.
4. Whipple AO. Pancreaticoduodenectomy for Islet Carcinoma : A
Five-Year Follow-Up. Ann Surg 1945; 121: 847-52. 
5. Gilsdorf RB, Spanos P. Factors influencing morbidity and mortality
in pancreaticoduodenectomy. Ann Surg 1973; 177: 332-7. 
6. Fernandez-del Castillo C, Morales-Oyarvide V, McGrath D, Wargo
JA, Ferrone CR, Thayer SP, et al. Evolution of the Whipple
procedure at the Massachusetts General Hospital. Surgery 2012;
152(3 Suppl 1): S56-63.
7. Siegel R, Naishadham D, Jemal A. Cancer statistics, 2013. CA
Cancer J Clin 2013; 63: 11-30.
8. Tewari M, Hazrah P, Kumar V, Shukla HS. Options of restorative
pancreaticoenteric anastomosis following
pancreaticoduodenectomy: a review. Surg Oncol 2010; 19: 17-26. 
9. Butturini G, Marcucci S, Molinari E, Mascetta G, Landoni L, Crippa
S, et al. Complications after pancreaticoduodenectomy: the
problem of current definitions. J Hepatobiliary Pancreat Surg
2006; 13: 207-11. 
10. Bassi C, Dervenis C, Butturini G, Fingerhut A, Yeo C, Izbicki J, et al.
Postoperative pancreatic fistula: an international study group
(ISGPF) definition. Surgery 2005; 138: 8-13. 
11. Waugh JM. Radical resection of head of pancreas and total
pancreatectomy. J Am Med Assoc 1948; 137: 141-4. 
12. Schoellhammer HF, Fong Y, Gagandeep S. Techniques for
prevention of pancreatic leak after pancreatectomy.
Hepatobiliary Surg Nutr 2014; 3: 276-87. 
13. Ohigashi H, Ishikawa O, Eguchi H, Sasaki Y, Yamada T, Kishi K, et al.
A simple and safe anastomosis in pancreaticogastrostomy using
mattress sutures. Am J Surg 2008; 196: 130-4. 
14. Delcore R, Thomas JH, Pierce GE, Hermreck AS.
Pancreatogastrostomy: a safe drainage procedure after
pancreatoduodenectomy. Surgery 1990; 108: 641-5;
discussion 5-7.
15. Flautner L, Tihanyi T, Szecseny A. Pancreatogastrostomy: an ideal
complement to pancreatic head resection with preservation of
the pylorus in the treatment of chronic pancreatitis. Am J Surg
1985; 150: 608-11. 
16. Yeo CJ, Cameron JL, Maher MM, Sauter PK, Zahurak ML, Talamini
MA, et al. A prospective randomized trial of
pancreaticogastrostomy versus pancreaticojejunostomy after
pancreaticoduodenectomy. Ann Surg 1995; 222: 580-8; discussion
8-92. 
17. Clerveus M, Morandeira-Rivas A, Picazo-Yeste J, Moreno-Sanz C.
Pancreaticogastrostomy versus pancreaticojejunostomy after
pancreaticoduodenectomy: a systematic review and meta-
analysis of randomized controlled trials. J Gastrointest Surg 2014;
18: 1693-704. 
18. Shen Y, Jin W. Reconstruction by Pancreaticogastrostomy versus
Pancreaticojejunostomy following Pancreaticoduodenectomy: A
Meta-Analysis of Randomized Controlled Trials. Gastroenterol Res
Pract 2012; 2012: 627095. 
19. Xiong JJ, Tan CL, Szatmary P, Huang W, Ke NW, Hu WM, et al. Meta-
analysis of pancreaticogastrostomy versus
pancreaticojejunostomy after pancreaticoduodenectomy. Br J
Surg 2014; 101: 1196-208. 
20. Chen Z, Song X, Yang D, Li Y, Xu K, He Y. Pancreaticogastrostomy
versus pancreaticojejunostomy after pancreaticoduodenectomy:
a meta-analysis of randomized control trials. Eur J Surg Oncol
2014; 40: 1177-85. 
21. Lei P, Fang J, Huang Y, Zheng Z, Wei B, Wei H.
Pancreaticogastrostomy or pancreaticojejunostomy? Methods of
digestive continuity reconstruction after
pancreaticodudenectomy: a meta-analysis of randomized
controlled trials. Int J Surg 2014; 12: 1444-9. 
22. Hallet J, Zih FS, Deobald RG, Scheer AS, Law CH, Coburn NG, et al.
The impact of pancreaticojejunostomy versus
pancreaticogastrostomy reconstruction on pancreatic fistula after
pancreaticoduodenectomy: meta-analysis of randomized
controlled trials. HPB (Oxford) 2015; 17: 113-22. 
23. Menahem B, Guittet L, Mulliri A, Alves A, Lubrano J.
Pancreaticogastrostomy is superior to pancreaticojejunostomy
for prevention of pancreatic fistula after
pancreaticoduodenectomy: an updated meta-analysis of
randomized controlled trials. Ann Surg 2015; 261: 882-7. 
24. Que W, Fang H, Yan B, Li J, Guo W, Zhai W, et al.
Pancreaticogastrostomy versus pancreaticojejunostomy after
pancreaticoduodenectomy: a meta-analysis of randomized
controlled trials. Am J Surg 2015; 209: 1074-82. 
25. Jakhmola CK, Kumar A. Whipple's pancreaticoduodenectomy:
Outcomes at a tertiary care hospital. Med J Armed Forces India
2014; 70: 321-6. 
26. Balachandran P, Sikora SS, Raghavendra Rao RV, Kumar A, Saxena
R, Kapoor VK. Haemorrhagic complications of
pancreaticoduodenectomy. ANZ J Surg 2004; 74: 945-50. 
27. Aslam T, Masood R, Maher M. Early complications following
pancreatico-duodenectomy. J Coll Physicians Surg Pak 2005; 15:
708-11. 
28. Pal KM, Bari H, Nasim S. Pancreaticoduodenectomy: a developing
country perspective. J Pak Med Assoc 2011 61: 232-5. 
J Pak Med Assoc
1624 T. Chawla, H. Bari, S. Effendi
